2.6
2023

Increasing the dosing interval of dupilumab in patients with severe asthma and chronic rhinosinusitis with nasal polyps

Show more: Authors information and Publication history
Authors Information

La Fama Allergy Medical Center, Murcia, Spain

History

Published: 15 September 2025
Accepted: 10 September 2025
Received: 19 April 2025

KEY WORDS
Dupilumab; Severe eosinophilic asthma; Chronic rhinosinusitis with nasal polyps (CRSwNP); Biological therapies Increasing

Table of Content: Online First

European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024